ArticleNature communications2024

Nanoparticles targeting mutant p53 overcome chemoresistance and tumor recurrence in non-small cell lung cancer.

Yu-Yang Bi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.